Long-Term Multi-Institutional Outcomes of 5-Fraction Ablative Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) for Inoperable Pancreas Cancer With Median Prescribed Biologically Effective Dose of 100 Gy10

dc.contributor.authorChuong, M. D.
dc.contributor.authorKirsch, C.
dc.contributor.authorHerrera, R.
dc.contributor.authorRubens, M.
dc.contributor.authorGungor, G.
dc.contributor.authorSchaff, E. M.
dc.contributor.authorDolan, J.
dc.contributor.authorKim, J.
dc.contributor.authorMittauer, K. E.
dc.contributor.authorKotecha, R.
dc.contributor.authorGutierrez, A.
dc.contributor.authorDoemer, A. J.
dc.contributor.authorUgurluer, G.
dc.contributor.authorKwon, D.
dc.contributor.authorKhan, G.
dc.contributor.authorAlvarez, D.
dc.contributor.authorUcar, A.
dc.contributor.authorAsbun, H.
dc.contributor.authorOzyar, E.
dc.contributor.authorParikh, P. J.
dc.date.accessioned2025-10-16T15:18:27Z
dc.date.issued2021
dc.identifier.otherWOS:000715803801632
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7148
dc.publisherELSEVIER SCIENCE INC
dc.sourceINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
dc.titleLong-Term Multi-Institutional Outcomes of 5-Fraction Ablative Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) for Inoperable Pancreas Cancer With Median Prescribed Biologically Effective Dose of 100 Gy10
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar